Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 300.50
Ask: 310.50
Change: 0.00 (0.00%)
Spread: 10.00 (3.328%)
Open: 300.00
High: 300.00
Low: 300.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Listing Six Monthly Return

27 Nov 2009 12:16

RNS Number : 2071D
Oxford Biomedica PLC
27 November 2009
 



For Immediate Release

27 November 2009

OXFORD BIOMEDICA PLC

BLOCK LISTING SIX MONTHLY RETURN

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Share Option Scheme

Period of return:

From:

29 May 2009

To:

27 November 2009

Balance of unallotted securities under scheme(s) from previous return:

4,223,564 Ordinary Shares of 1p each

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

None

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

187,025 Ordinary Shares of 1p each

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

4,036,539 Ordinary Shares of 1p each

Name of contact:

Andrew Wood, Company Secretary

Telephone number of contact:

01865 783000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRCKOKKBBDDFDB
Date   Source Headline
3rd Dec 20189:53 amRNSTotal Voting Rights
3rd Dec 20187:00 amRNSLonger term Kymriah efficacy and safety data
23rd Nov 201810:41 amRNSDirector Dealings
23rd Nov 20187:00 amRNSOxford Biomedica form digital framework initiative
9th Nov 20187:00 amRNSBlock listing application
1st Nov 20182:41 pmRNSTotal Voting Rights
25th Oct 20187:00 amRNSAxovant Doses First Patient with AXO-Lenti-PD
22nd Oct 20184:39 pmRNSDirector Dealings / Market Share Purchase
5th Oct 20187:00 amRNSDetails of alliance with Orchard Therapeutics
1st Oct 20189:41 amRNSTotal Voting Rights
24th Sep 201812:20 pmRNSDirector/PDMR Shareholding
20th Sep 201810:57 amEQSHardman & Co Research: Oxford BioMedica (OXB): Partnering strategy delivering profitability
13th Sep 20187:00 amRNSOxford BioMedica Interim Results
13th Sep 20187:00 amRNSOxford BioMedica further capacity expansion
3rd Sep 20189:18 amRNSTotal Voting Rights
28th Aug 20187:00 amRNSKymriah® receives European Commission Approval
22nd Aug 201811:58 amRNSDirector/PDMR Shareholding
15th Aug 20187:00 amRNSRNS notice of results OXB
14th Aug 20187:15 amEQSHardman & Co Research: Oxford BioMedica (OXB): Risk-sharing in cystic fibrosis gene-therapy
13th Aug 201810:55 amRNSDirector/PDMR Shareholding
13th Aug 201810:48 amRNSDirector/PDMR Shareholding
10th Aug 201811:39 amRNSPDMR Dealings / Market Share Sale
10th Aug 201811:36 amRNSDirector Dealings / Market Share Sale and Purchase
8th Aug 20182:45 pmRNSShare Options and LTIPs Granted
6th Aug 20187:02 amRNSPartnership for Cystic Fibrosis Gene Therapy
1st Aug 20189:53 amRNSTotal Voting Rights
23rd Jul 201812:54 pmRNSDirector Dealings / Market Share Purchase
2nd Jul 201810:25 amRNSDirectorate Change
2nd Jul 20189:47 amRNSTotal Voting Rights
29th Jun 20181:37 pmRNSKymriah receives positive CHMP opinion
25th Jun 20185:19 pmRNSHoldings in Company
22nd Jun 201812:05 pmRNSConfirmation of change of Auditor
22nd Jun 201812:03 pmRNSDirector Dealings / Market Share Purchase
21st Jun 20185:52 pmRNSHoldings in Company
14th Jun 20189:51 amEQSHardman & Co Research: Oxford BioMedica (OXB): Gene-therapy for Parkinson's: clinical progression
6th Jun 20187:00 amRNSOXB and Axovant Sciences Licence Agreement
4th Jun 20186:08 pmRNSDirectorate Change
1st Jun 20189:24 amRNSBlock Listing Return
1st Jun 20189:19 amRNSTotal Voting Rights
30th May 20184:23 pmRNSHoldings in Company
29th May 20181:21 pmRNSResult of General Meeting
29th May 20181:21 pmRNSResult of AGM
23rd May 20181:40 pmRNSDirector Dealings / Market Share Purchase
4th May 20187:00 amRNSProposed Share Capital Consolidation
2nd May 20187:00 amRNSKymriah receives FDA approval for DLBCL
1st May 20189:37 amRNSTotal Voting Rights
26th Apr 20183:33 pmRNSHolding(s) in Company
26th Apr 20187:30 amRNS2017 Annual Report and Accounts & AGM Notification
23rd Apr 201811:46 amRNSDirector Dealings / Market Share Purchase
11th Apr 20182:11 pmRNSDirector Dealings / Market Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.